Persistent anxiety that resists traditional treatments creates exhausting cycles of worry, avoidance, and physical symptoms that dominate daily life. At Mend The Mind, we provide specialized anxiety treatment combining rapid-acting ketamine therapy with comprehensive psychiatric care and therapeutic support. Our approach addresses both the neurobiological mechanisms maintaining anxiety and the psychological patterns keeping you trapped in fear and hypervigilance.
Anxiety disorders represent the most common mental health conditions, affecting nearly 30% of adults at some point in their lives. While everyone experiences occasional anxiety, anxiety disorders involve persistent, excessive worry or fear that significantly impairs functioning and doesn’t resolve with reassurance or logical thinking.
Generalized anxiety disorder creates chronic, uncontrollable worry about various life domains—work, health, relationships, finances—accompanied by physical tension, restlessness, fatigue, difficulty concentrating, irritability, and sleep problems. The worry feels impossible to turn off, dominating your mental space and exhausting you with constant vigilance against imagined threats.
Social anxiety disorder involves intense fear of social situations where you might be judged, embarrassed, or humiliated. This extends beyond normal shyness to severe anxiety that causes significant avoidance of social interactions, work presentations, or any situation requiring visibility. Performance anxiety, fear of conversation, and worry about others noticing your anxiety create self-reinforcing cycles of avoidance and isolation.
Panic disorder produces recurrent, unexpected panic attacks—sudden surges of intense fear accompanied by physical symptoms including rapid heartbeat, sweating, trembling, shortness of breath, chest pain, nausea, dizziness, and feelings of unreality or losing control. The fear of future panic attacks often leads to agoraphobia, avoiding situations where escape might be difficult or help unavailable.
Anxiety’s physical manifestations are as disabling as the psychological symptoms. Chronic muscle tension, headaches, digestive problems, fatigue from hypervigilance, sleep disruption, and cardiovascular stress from sustained activation all take cumulative toll on your health and quality of life.
First-line anxiety treatments include SSRIs, SNRIs, buspirone, and when necessary, carefully managed benzodiazepines, combined with cognitive behavioral therapy. These approaches help many patients but leave approximately 50% with inadequate relief—defined as treatment-resistant anxiety.
Antidepressants require 4-8 weeks to show effects, providing no relief during the waiting period when anxiety remains severe. Many patients try multiple medications without finding adequate symptom control. Benzodiazepines work rapidly but carry dependence risk, cognitive side effects, and diminishing effectiveness with long-term use, making them problematic for chronic anxiety management.
Exposure therapy—the most effective CBT approach for many anxiety disorders—requires facing feared situations systematically. When anxiety is severe, mustering the courage and capacity to engage in exposures feels impossible. You need some symptom reduction before you can do the work that produces lasting change, creating a frustrating catch-22.
Avoidance, anxiety’s primary coping mechanism, provides short-term relief while strengthening long-term fear. Each avoided situation reinforces the belief that the situation is dangerous and you cannot handle it. Yet forcing yourself into feared situations without adequate support risks overwhelming panic that worsens rather than improves anxiety.
The chronicity of untreated anxiety creates secondary problems. Depression develops frequently, substance use may emerge as self-medication attempt, relationships suffer under constant worry and avoidance, and career opportunities narrow as anxiety limits what you can tackle. These secondary problems then maintain anxiety, creating complex clinical pictures resistant to simple interventions.
Ketamine addresses anxiety through mechanisms distinct from traditional anxiolytics. As an NMDA receptor antagonist, ketamine modulates glutamate signaling involved in anxiety response and fear conditioning. It enhances neuroplasticity, allowing your brain to form new neural pathways beyond habitual anxiety patterns. The medication reduces activity in brain regions maintaining fear responses and worry loops, providing relief from constant hypervigilance.
Research evidence for ketamine in anxiety disorders is emerging but promising. Studies in social anxiety disorder show 33% of participants experiencing significant symptom reduction lasting two weeks following single infusions. Generalized anxiety disorder research demonstrates 50% symptom reduction lasting over seven months with repeated treatments. Limited evidence suggests benefits for panic disorder, though research here is primarily case reports rather than controlled trials.
Ketamine’s anxiolytic effects often appear rapidly—within hours of infusion—though repeated treatments produce more sustained benefits. The immediate relief can break anxiety’s grip enough to engage in therapeutic work previously too overwhelming to attempt. This makes ketamine particularly valuable when combined with exposure therapy or other psychological interventions.
Studies demonstrate strongest effects when ketamine is part of comprehensive treatment including ongoing therapy rather than standalone intervention. The neuroplastic window ketamine creates allows therapeutic learning to consolidate more effectively, potentially producing longer-lasting change than either treatment alone.
Our standard ketamine protocol for anxiety consists of six IV infusions delivered over 2-3 weeks. Mental health infusions last 40-60 minutes under continuous medical monitoring by our Board Certified CRNA. Dosing adjusts based on your response, side effects, and specific anxiety presentation.
Many patients notice reduced anxiety within hours of their first infusion—decreased worry, lessened physical tension, improved sleep, and greater capacity to engage with avoided situations. Full benefits typically emerge across the initial series rather than from single treatments.
Maintenance infusions sustain improvements long-term. Frequency varies between patients, with most requiring boosters every 4-8 weeks initially, potentially spacing further as anxiety stabilizes. Your maintenance schedule develops based on symptom return patterns and functional impairment.
Ketamine troches provide at-home maintenance therapy between IV sessions or as standalone treatment for some patients. The self-administered format offers flexibility for managing anxiety flares while maintaining therapeutic benefits under medical supervision. Troches work well for sustaining improvements achieved through IV therapy.
Combining ketamine with psychotherapy enhances outcomes beyond either treatment alone. Your therapist provides support during ketamine sessions as anxiety-related material emerges, helps you practice approaching feared situations with reduced anxiety during the neuroplastic window, and facilitates integration of insights and emotional shifts into daily life.
KAP is particularly valuable for social anxiety and panic disorder where exposure work is essential but difficult. The reduced anxiety during and following ketamine sessions creates opportunities for therapeutic exposure that might otherwise feel impossible.
Anxiety lives in your body as much as your mind—chronic muscle tension, shallow breathing, digestive distress, and hypervigilant nervous system states maintain anxiety even when cognitive interventions address worried thoughts. Somatic facilitation during ketamine sessions helps you work with these physical dimensions.
You’ll learn to track your nervous system states, recognize early signs of anxiety activation, practice regulation techniques reducing physical anxiety symptoms, and release chronic tension patterns maintained by years of hypervigilance. This body-level work complements cognitive and emotional processing, addressing anxiety’s full bio-psycho-social complexity.
Comprehensive psychiatric medication management ensures your anxiety treatment optimizes all available interventions. We provide expert prescription and monitoring of SSRIs, SNRIs, or other antidepressants for anxiety, buspirone or other non-benzodiazepine anxiolytics, carefully managed benzodiazepines when appropriate, and medications addressing comorbid conditions like depression or insomnia.
Your medication regimen integrates with ketamine therapy rather than competing with it. We monitor for interactions, adjust doses as ketamine reduces anxiety, and help you potentially taper medications that become unnecessary as your symptoms improve.
Anxiety response to ketamine varies significantly between individuals. Some experience dramatic relief—50% or greater symptom reduction—while others notice moderate improvement or minimal benefit. Social anxiety and GAD show stronger research support than panic disorder or specific phobias.
Initial effects often appear within hours to days of first infusion, though sustained benefits require the full initial series. Peak improvement typically emerges 1-2 weeks into treatment, with continued gains possible across multiple months of maintenance therapy.
The durability of ketamine’s anxiolytic effects ranges from days to months depending on anxiety severity, whether you engage in concurrent therapy, and maintenance treatment frequency. Most patients need regular boosters to sustain benefits rather than achieving permanent anxiety resolution from initial series alone.
Realistic expectations matter. Ketamine rarely eliminates anxiety completely but can reduce symptoms enough to improve functioning significantly—returning to work, engaging socially, sleeping better, and experiencing periods of calm previously unavailable. Even partial response often enables therapeutic work producing further improvement.
You may benefit from our anxiety treatment if traditional medications provide inadequate relief, therapy alone isn’t sufficient despite good engagement, your anxiety significantly impairs work and relationships, or you need rapid relief to prevent crisis or enable therapeutic work.
Ketamine is not first-line anxiety treatment. You should have tried appropriate SSRIs or SNRIs, engaged in evidence-based therapy when possible, and explored other conventional approaches before considering ketamine. Our treatment serves patients with treatment-resistant anxiety rather than those just beginning treatment.
Medical and psychiatric screening ensures safety. Uncontrolled cardiovascular disease, active substance use disorders, and certain psychiatric conditions require careful evaluation. We’ll assess whether ketamine is safe and appropriate for your specific situation.
Living with treatment-resistant anxiety doesn’t have to be your permanent reality. Our comprehensive approach combines innovative ketamine therapy with expert psychiatric care and therapeutic support. We’re here to help you find the relief that’s eluded you with traditional treatments.
[1] Glue, P., et al. (2017). “Ketamine’s dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders.” Journal of Psychopharmacology, 31(10), 1302-1305.
https://journals.sagepub.com/doi/10.1177/0269881117705089
[2] Taylor, J. H., et al. (2018). “Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial.” Neuropsychopharmacology, 43(2), 325-333.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729569/
Conditions Treated
1201 U.S. Highway 10 W, Unit A4, Livingston 59047
Mend The Mind is a psychiatric practice in Livingston, Montana, specializing in ketamine therapy and comprehensive mental health services for adults. With anesthesia expertise ensuring the highest safety standards, we bring evidence-based treatment to rural Montana communities.